Comparative Drug Value
Cross-source consensus on Comparative Drug Value from 1 sources and 5 claims.
1 sources · 5 claims
Risks & contraindications
Comparisons
Evidence quality
Highlighted claims
- The article states that recombinant human insulin costs about $480 per year, while insulin analogs peaked around $5,200 per year. — Big Pharma and the Corruption of Medical Knowledge
- Insulin is used as an example of expensive newer therapies displacing cheaper older therapies without adequate evidence of superiority for many patients. — Big Pharma and the Corruption of Medical Knowledge
- The article claims there is not evidence that insulin analogs are superior to recombinant human insulin for many type 2 diabetics. — Big Pharma and the Corruption of Medical Knowledge
- The article argues that money spent on unnecessarily expensive insulin could instead support lifestyle and community health interventions. — Big Pharma and the Corruption of Medical Knowledge
- Countries with health technology assessment are described as starting many type 2 diabetics on older insulin and reserving analogs for those who do poorly. — Big Pharma and the Corruption of Medical Knowledge